Pilot phase II trial of ACH 3102 in combination with sofosbuvir in treatment-naive patients with hepatitis C

Trial Profile

Pilot phase II trial of ACH 3102 in combination with sofosbuvir in treatment-naive patients with hepatitis C

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Odalasvir (Primary) ; Sofosbuvir
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms Proxy
  • Sponsors Achillion Pharmaceuticals
  • Most Recent Events

    • 17 Sep 2015 Interim results published in an Achillion Pharmaceuticals media release.
    • 17 Sep 2015 Status changed from recruiting to completed, according to an Achillion Pharmaceuticals media release.
    • 25 Apr 2015 Results published in an Achillion media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top